Cita APA

Shoji, T., Takatori, E., Kaido, Y., Omi, H., Yokoyama, Y., Mizunuma, H., . . . Sugiyama, T. (2014). A phase I study of irinotecan and pegylated liposomal doxorubicin in recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study). Springer Berlin Heidelberg.

Citación estilo Chicago

Shoji, Tadahiro, et al. A Phase I Study of Irinotecan and Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 104 Study). Springer Berlin Heidelberg, 2014.

Cita MLA

Shoji, Tadahiro, et al. A Phase I Study of Irinotecan and Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 104 Study). Springer Berlin Heidelberg, 2014.